Organization
Department of Oncology, Rigshospitalet, University of Copenhagen
2 abstracts
Abstract
Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC).Org: Norwegian University of Science and Technology (NTNU), Department of Thoracic Medicine, Haukeland University Hospital, Department of Oncology, Oslo University Hospital, Oslo, Oslo, Norway, Stavanger University Hospital, Department of Oncology, Odense University Hospital,
Abstract
Larotrectinib long-term efficacy and safety in adult patients (pts) with tropomyosin receptor kinase (TRK) fusion cancer.Org: University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, Division of Medical Oncology, National Cancer Center Singapore and Duke-NUS Medical School, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Oregon Health and Science University,